# Itraconazole to Prevent Recurrent Barrett's Esophagus

> **NCT05609253** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Kansas Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Barrett Oesophagitis With Dysplasia

## Interventions

- **DRUG:** Itraconazole in capsule form
- **DRUG:** Itraconazole in solution form

## Key facts

- **NCT ID:** NCT05609253
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-09-14
- **Primary completion:** 2024-02-23
- **Final completion:** 2026-06-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05609253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05609253, "Itraconazole to Prevent Recurrent Barrett's Esophagus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05609253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*